 Heres a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks Biotech stocks that hit hit 52-week highs March 5. Arcus Biosciences Inc NYSE: RCUS Arcturus Therapeutics Ltd NASDAQ: ARCT BioMarin Pharmaceutical Inc. NASDAQ: BMRN Centogene NV NASDAQ: CNTG Cue Biopharma Inc NASDAQ: CUE Forty Seven Inc NASDAQ: FTSV Inovio Pharmaceuticals Inc NASDAQ: INO Molecular Templates Inc NASDAQ: MTEM Natera Inc NASDAQ: NTRA Ocular Therapeutix Inc NASDAQ: OCUL Piper Sandler lifted the price target for the shares from 7 to 11 Quest Diagnostics Inc NYSE: DGX announced plans to launch a COVID-19 test service Regeneron Pharmaceuticals Inc NASDAQ: REGN Syndax Pharmaceuticals Inc NASDAQ: SNDX Zynex Inc. NASDAQ: ZYXI Down In The Dumps Biotech stocks that hit 52-week lows March 5. Aldeyra Therapeutics Inc NASDAQ: ALDX AngioDynamics, Inc. NASDAQ: ANGO ANI Pharmaceuticals Inc Common Stock NASDAQ: ANIP Aytu Bioscience Inc NASDAQ: AYTU Celcuity Inc NASDAQ: CELC Chembio Diagnostics Inc NASDAQ: CEMI Eagle Pharmaceuticals Inc NASDAQ: EGRX Eiger Biopharmaceuticals Inc NASDAQ: EIGR Enlivex Therapeutics Ltd NASDAQ: ENLV Evogene Ltd NASDAQ: EVGN EXACT Sciences Corporation NASDAQ: EXAS Glaukos Corp NYSE: GKOS Lantheus Holdings Inc NASDAQ: LNTH Mylan NV NASDAQ: MYL Neurometrix Inc NASDAQ: NURO Organogenesis Holdings Inc NASDAQ: ORGO Orthofix Medical Inc NASDAQ: OFIX Passage Bio Inc NASDAQ: PASG went public last week Polarityte Inc NASDAQ: PTE STRATA Skin Sciences Inc NASDAQ: SSKN SurModics, Inc. NASDAQ: SRDX reacted to first-quarter results T2 Biosystems Inc NASDAQ: TTOO Xeris ... 